| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/15/2011 | CA2426440C Quinazoline derivatives as kinase inhibitors |
| 03/15/2011 | CA2415611C Biologically active macrolides, compositions, and uses thereof |
| 03/15/2011 | CA2404196C Medical emulsion for lubrication and delivery of drugs |
| 03/15/2011 | CA2402038C Lpa receptor agonists and antagonists and methods of use |
| 03/15/2011 | CA2397366C Methanocarba cycloalkyl nucleoside analogues |
| 03/15/2011 | CA2396030C Camptothecin .beta.-alanine esters with topoisomerase i inhibition |
| 03/15/2011 | CA2394809C Benzazole derivatives and their use as jnk modulators |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/15/2011 | CA2374398C Immunoconjugates having high binding affinity |
| 03/15/2011 | CA2360415C Benzimidazole vascular damaging agents |
| 03/15/2011 | CA2338982C Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 03/15/2011 | CA2277192C Nuclear transfer with differentiated fetal and adult donor cells |
| 03/15/2011 | CA2188422C Bifunctional protein, preparation and use |
| 03/10/2011 | WO2011029028A2 Targeted delivery using tissue-specific peptidomimetic ligands |
| 03/10/2011 | WO2011029008A2 Synbodies to akt1 |
| 03/10/2011 | WO2011029001A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | WO2011028995A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | WO2011028947A2 Heterocyclic compounds for the inhibition of pask |
| 03/10/2011 | WO2011028864A1 Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer |
| 03/10/2011 | WO2011028860A2 Compounds and compositions for treating cancer |
| 03/10/2011 | WO2011028811A2 Dual variable domain immunoglobulins and uses thereof |
| 03/10/2011 | WO2011028800A2 Treatment of cognitive dysfunction with gangliosides |
| 03/10/2011 | WO2011028743A1 Pharmaceutical formulations for indibulin |
| 03/10/2011 | WO2011028733A1 Compositions and minimally invasive methods for treating cancer |
| 03/10/2011 | WO2011028651A1 Inhibitors of human 15-lipoxygenase-1 |
| 03/10/2011 | WO2011028594A2 Cancer starvation therapy |
| 03/10/2011 | WO2011028485A2 Tumoricidal, bactericidal, or viricidal macrophage activation |
| 03/10/2011 | WO2011028334A2 Synthesis and isolation of dendrimer systems |
| 03/10/2011 | WO2011028255A2 Desferrithiocin polyether analogues and uses thereof |
| 03/10/2011 | WO2011028135A1 Kinase inhibitors, prodrug forms thereof and their use in therapy |
| 03/10/2011 | WO2011027980A2 Tumor cell-killing peptides |
| 03/10/2011 | WO2011027829A1 Composition containing rna derived from lactic acid bacterium as active ingredient |
| 03/10/2011 | WO2011027807A1 Immunity inducer |
| 03/10/2011 | WO2011027330A1 Inhibition of histone acetyltransferases by ctk7a and methods thereof |
| 03/10/2011 | WO2011027249A2 Benzimidazole derivatives |
| 03/10/2011 | WO2011027132A1 Clec14a inhibitors |
| 03/10/2011 | WO2011027081A2 Novel derivatives of 5,6,7,8-tetrahydroindolizine inhibiting hsp90, compositions containing same, and use thereof |
| 03/10/2011 | WO2011026912A2 Mir-10a inhibitors and inhibitors of hoxb1 and/or hoxb3 repressors in the blocking of metastatic behaviour of pancreatic cancer |
| 03/10/2011 | WO2011026911A1 Bipyridines useful for the treatment of proliferative diseases |
| 03/10/2011 | WO2011026904A1 Pyrazinylpyridines useful for the treatment of proliferative diseases |
| 03/10/2011 | WO2011026898A2 Drug activation system |
| 03/10/2011 | WO2011026401A1 Anti-tumor natural medicines coupled with nitric oxide donors and pharmaceutical uses thereof |
| 03/10/2011 | WO2011026242A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| 03/10/2011 | WO2011026219A1 Combination therapy for cancer comprising a platinum -based antineoplastic agent and a biocompatible electron donor |
| 03/10/2011 | WO2011009020A3 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
| 03/10/2011 | WO2010132389A3 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression |
| 03/10/2011 | WO2010129947A3 Alpha thymosin peptides as vaccine enhancers |
| 03/10/2011 | WO2010126279A3 Cytokeratin 17-specific human antibody |
| 03/10/2011 | WO2010121226A3 Anticancer agents |
| 03/10/2011 | WO2010120121A3 Target-specific non-antibody protein and method for preparing the same |
| 03/10/2011 | WO2010108657A3 C5a binding nucleic acids and the use thereof |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110060605 Methods for predicting responsiveness of a disease or disorder to a receptor tyrosine kinase inhibitor by analysis of mutations in pik3ca |
| 03/10/2011 | US20110060130 Neutralizing human anti-igfr antibody |
| 03/10/2011 | US20110060059 Inhibition of the Survival of Bladder Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110060058 Inhibition of the Survival of Ovarian Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110060057 Inhibition of the Survival of Skin Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110060056 Inhibition of the Survival of Gastric Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110060055 Inhibition of the Survival of Lymphoma by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110060054 2-methylene-5-substituted-methylenecyclopentanone derivatives and use thereof |
| 03/10/2011 | US20110060050 Sgk1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas |
| 03/10/2011 | US20110060049 Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same |
| 03/10/2011 | US20110060047 Approaches to treat cancer using hb-egf inhibitors |
| 03/10/2011 | US20110060043 Inhibitors of cell proliferation and uses thereof |
| 03/10/2011 | US20110060038 Nitrogenated trans-stilbene analogs, method for the obtention and medical applications thereof |
| 03/10/2011 | US20110060036 Branched Multifunctional Nanoparticle Conjugates And Their Use |
| 03/10/2011 | US20110060034 Cell transdifferentiation into brown adipocytes |
| 03/10/2011 | US20110060029 Method of treating cancer by modulating epac |
| 03/10/2011 | US20110060028 Combination therapy |
| 03/10/2011 | US20110060024 Modulators of ATP-Binding Cassette Transporters |
| 03/10/2011 | US20110060021 Histone deacetylase inhibitors and uses thereof |
| 03/10/2011 | US20110060014 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 03/10/2011 | US20110060013 Thiazoles and pyrazoles useful as kinase inhibitors |
| 03/10/2011 | US20110060011 Oxazole compounds compositions and methods of use |
| 03/10/2011 | US20110060010 Salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione and derivatives thereof, or polymorphs of salts, process for preparing same and use thereof |
| 03/10/2011 | US20110060009 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/10/2011 | US20110060005 Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
| 03/10/2011 | US20110060004 Imidazo-Pyridine Derivatives as Activin-Like Receptor Kinase (ALK4 or ALK5) Inhibitors |
| 03/10/2011 | US20110060001 Thienopyridone derivatives as amp- activated protein kinase (ampk) activators |
| 03/10/2011 | US20110060000 Acridine analogs in the treatment of gliomas |
| 03/10/2011 | US20110059994 Composition for preventing or treating brain cancers |
| 03/10/2011 | US20110059989 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases |
| 03/10/2011 | US20110059976 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 03/10/2011 | US20110059974 Novel retinamide retinoic acid metabolism blocking agents |
| 03/10/2011 | US20110059971 Derivatives of 4-aminopiperidine and their use as a medicament |
| 03/10/2011 | US20110059970 4-phenyl-1,3-thiazoles and 4-phenyl-1,3-oxazoles derivatives as cannabinoid receptor ligands |
| 03/10/2011 | US20110059965 Bicyclic derivatives as modulators of ion channels |
| 03/10/2011 | US20110059963 Compounds and methods for kinase modulation, and indications therefor |
| 03/10/2011 | US20110059961 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
| 03/10/2011 | US20110059960 Method of treating inherited severe neutropenia |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059956 Therapeutic agent for pain |
| 03/10/2011 | US20110059955 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 03/10/2011 | US20110059953 Compounds for use in stabilizing p53 mutants |
| 03/10/2011 | US20110059951 HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 03/10/2011 | US20110059945 S1P Receptor Modulating Compounds and Use Thereof |
| 03/10/2011 | US20110059944 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 03/10/2011 | US20110059943 Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer |
| 03/10/2011 | US20110059938 New chemical compounds |
| 03/10/2011 | US20110059936 C-met protein kinase inhibitors |